Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

BackgroundMineralocorticoid receptor antagonist (MRA) therapy may be beneficial to patients with atrial fibrillation (AF), but little is known about their use in patients with AF and subsequent outcomes. Methods and ResultsIn order to better understand MRA use and subsequent outcomes, we performed a...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Marat Fudim, Peter R. Liu, Peter Shrader, Rosalia G. Blanco, Larry A. Allen, Gregg C. Fonarow, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Elaine Hylek, Alan S. Go, Laine Thomas, Eric D. Peterson, Jonathan P. Piccini
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2018-04-01
Reeks:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Onderwerpen:	atrial fibrillation mineralocorticoid antagonist stroke
Online toegang:	https://www.ahajournals.org/doi/10.1161/JAHA.117.007987
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!